Nivolumab plus ipilimumab tops sunitinib for advanced renal CA
(HealthDay)—For patients with previously untreated clear-cell advanced renal-cell carcinoma, nivolumab plus ipilimumab is associated with better overall survival than sunitinib, according to a study published online March ...
Mar 23, 2018
0
4